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Serological characterization of human cell surface phenotypes through typing 
of cultured cell panels and tissues with monoclonal antibodies (mAb) 1  has revealed 
a  high  degree  of antigenic  diversity  on  somatic  cells.  Expression  of a  large 
number of antigenic systems has been correlated with differentiation pathways 
(providing markers  for cell  lineages or distinct stages within a  differentiation 
pathway), with growth characteristics and cell proliferation, or with the trans- 
formed phenotype of tumor cells (1-4).  Coordinate expression  of a  series  of 
surface antigenic systems was found to be characteristic for certain differentiated 
cell types, and a cell type-specific sequence of changes in these antigenic patterns 
was  found to  accompany cellular differentiation and  maturation steps.  These 
principles were established through serological analysis of normal and malignant 
cells of hematopoietic origin, and have been extended more recently to other 
human cell types (2,  5). While phenotypic variability on the human cell surface 
has been studied in considerable detail, little is known about the genes coding 
for most surface antigens and genes involved in coordinating the expression of 
multiple surface components to generate specific phenotypic patterns. 
Somatic cell  genetic analysis of antigen expression in rodent-human hybrid 
cells  has  provided  several  types of information concerning genes  controlling 
surface antigens and their interaction and organization in the human genome: 
(a) chromosomal assignment of genes coding for surface antigens (6); (b) iden- 
tification of subunit components of multimeric antigens coded for by different 
chromosomes (7-9); and (c) definition of regulatory controls of antigen expres- 
sion  related  to  cell  lineage  and  growth  characteristics,  including the  permis- 
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sive/nonpermissive  and  the  inducing/noninducing character  of differentiated 
rodent cells for the expression of human differentiation antigens (8). 
In  this  study,  we  describe  the  analysis  of eight  distinct  antigenic  systems 
controlled  by  human  chromosome  11,  including  the  putative  human  Thy-1 
antigen, K117 (25 kilodalton [kD] glycoprotein), and T43 (85 kD glycoprotein), 
a marker of malignant tumors derived from T43- epithelia (4). Our results, and 
those described by others (10,  11) indicate that a  large number of known gene 
loci coding for cell surface components are clustered in human chromosome 11, 
and that this chromosome carries several genes differentially expressed on cells 
undergoing hematopoietic and neuroectodermal differentiation. 
Materials and Methods 
Cell Lines.  19  mouse-human  hybrid clones  were  derived  in  the  laboratory of X. 
Breakefield (Yale University, New Haven, CT), from fusions between SK-N-BE(2) human 
neuroblastoma cells  and  N4TG-1  mouse neuroblastoma cells  (NSK  hybrid series),  or 
between  BE(2)-C human neuroblastoma cells and  NS20TG11E  mouse neuroblastoma 
cells (NBE  hybrid series)  as described  (12). Additional hybrid cell  lines  derived from 
fusions between human melanoma (LC and CE hybrid series) or normal kidney epithelial 
cells (LNK, ANK, and RC hybrid series) with mouse RAG, A9, or L cells, or with YH21 
Chinese hamster ovary cells, have been described (12-14).  SK-N-MC human neuroblas- 
toma cells were fused with mouse L cells to generate the LMC hybrid series. 
Chromosome Analysis of  Hybrid Cells.  The presence of human genetic material in hybrid 
cell lines was determined by four methods: (a) Isozyme analysis (enzymes listed in 12). (b) 
Karyotype analysis;  metaphase spreads were stained by trypsin-Giemsa techniques (15, 
16), or by the G11  method (17), or sequentially with both techniques. ~>25 metaphases 
were  evaluated for each  NSK,  CE,  and  LC  hybrid, and  10-25  metaphases for  NBE 
hybrids. (c) Cell surface markers; hybrid cells were tested in mixed hemadsorption assays 
(MHA) (see  below)  with mAb directed against 21  chromosomally mapped cell surface 
antigens (8, 12-14). (d) Southern blot analysis; presence of the distal end of the short arm 
of chromosome  11  was  confirmed by  DNA  hybridization techniques  with  the  pT22 
(HRAS1) and p/3pstd (/3-globin) probes, obtained from M. Wigler (Columbia University 
College of Physicians  and Surgeons, New York)  and T. Maniatis (Cold Spring Harbor 
Laboratory, Cold Spring Harbor,  NY), respectively, using standard procedures, as de- 
scribed (18). 
mAb and Serological Procedures.  mAb AbG344,  AbK117, AbMC139, and AbNP13 
were newly derived from mice immunized with cultured human astrocytoma (AbG344, 
AbK 117), or neuroblastoma cells (AbMC 139), or from a tissue extract (AbNP 13), follow- 
ing standard fusion, hybrid selection, and cloning procedures (19). The derivation of the 
other antibodies has been described (4,  5,  8,  19). MHA rosetting for the detection of 
surface antigens on cultured cells have been described (5, 12, 19). 
Immunohistochemical Procedures.  Tissues were quick-frozen in isopentane precooled in 
liquid nitrogen.  Frozen 5-#m  sections were cut, mounted on gelatin-coated slides, air- 
dried, and fixed in cold acetone. Avidin-biotin immunoperoxidase tests were carried out 
as described (20), using biotinylated horse anti-mouse IgG (Vector Labs, Burlington, CA) 
as second antibody. 
Immunochemical Procedures.  Cells were metabolically labeled with [~SS]methionine or 
[3H]glucosamine  (New England Nuclear, Boston, MA), and used for immunoprecipitation 
experiments following published procedures (19). 
Results 
Serological  and  Biochemical  Characteristics  of  Cell  Surface  Antigenic  Sys- 
tems.  Eight antigenic systems defined by mouse mAb are analyzed in this study, RETTIG ET  AL.  1605 
FIGURE  1.  Fluorogram of immunoprecipitates obtained with mAb and separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. (A) Extracts of 
[SH]glucosamine-labeled SK-GS-I (lanes A and B), U251MG cells (lane C), or concanavalin A- 
bound fractions  of [sSS]methionine-labeled LA-N-1 cells (lanes D and  E) were  tested  with 
AbG344 (lane A), AhK117 (lane C), AbMC139 (lane E), or unrelated  mouse mAb (lanes B 
and D). (B) Extracts of SK-RC-6 renal cancer cells (lanes A and B), SK-LC-8 lung cancer cells 
(lanes C and D), or normal lung fibroblasts (lanes E and F) were tested with AbJF23 (lanes B, 
D, and F) or unrelated  mouse mAb (lanes A, C, and E). Molecular masses of immunoprecipi- 
tated components are indicated at the right (kD). 
including  four  antigens  (K117,  MC139,  G344,  and  NP13)  detected  by  newly 
derived antibodies.  The antigenic systems can be distinguished  by three criteria: 
(a)  differential  expression  on  a  cultured  human  cell  panel,  (b)  biochemical 
properties,  and (c) differential expression on a  panel of reduced rodent-human 
somatic cell hybrids. 
K117 Antigenic System.  K 117  is a  25 kD glycoprotein (Fig.  1 A) expressed on 
a  small  range  of cultured  cell  types.  Fig.  2  summarizes  the  results  of typing  a 
panel of 120 human tumor cell lines and short-term cultures of normal cells for 
Kl17  expression.  Neuroblastomas,  astrocytomas,  sarcomas,  teratocarcinomas, 
and fibroblasts are K 117 +, whereas most melanocytic, epithelial, and hematopoi- 
etic  cell  lines  tested are  K117-.  Frozen  sections  of normal  human  tissues  were 
tested for K 117  expression  using the avidin-biotin  immunoperoxidase method. 
Strong K117 reactivity was found with neurons, neuropii,  and glial cells in both 
gray matter  and  white  matter  of adult  cortex  and  cerebellum  (Fig.  3).  Blood 
vessels (endothelium, smooth muscle cells) and connective tissue cells were K117 + 
in all tissues tested. In the liver, hepatocytes and bile ducts were antigen-negative. 
In  fetal thymus,  K117 + cells were found  in  the  septi (blood vessels, connective 
tissue  cells);  a  proportion  of thymocytes in  the  cortical  areas  was  also  K117 +, 
whereas fewer K117 + cells were located in medullary areas (Fig.  3). 
MC139 Antigenic System.  MC139  is a  35 kD glycoprotein (Fig.  1A) expressed 
on  a  distinct  range of cultured  human  cells.  All  normal  and  malignant  cells of 
neuroectodermal origin tested, most sarcomas, choriocarcinomas, and teratocar- 1606  CONTROL  OF  HUMAN  CELL  SURFACE  ANTIGENS  BY  CHROMOSOME 
Monoclonal antibody 
Kl17  MC139  Cell type 
Human ceils 
Neuroectederm-derived cells 
Neuroblastoma  OHtO~  ONOO~ 
Astrocytoma  OIICt,;:t,t,::  HlleUeeN 
Melanoma  OlO000100O  OINNNNNNNIt 
Melanocytes  O0  I0 
Sarcomas  Nlilllnll  NtIIIIIO~ 
Epithelial cells 
Normal kidney epithelia~ cells  000  000 
Renal cancer  000000000  0000000000 
Bladder cancer  00000  00000 
Colon cancer  O0000  O0000 
Breast cancer  00000000  go000000 
Lung cancer  00000  OIQO0 
Other cancers  0000000000  0000000000 
Choriocarcinoma  000  NI 
Teratocarcinoma  III  III 
Hernatopoietic cells 
B cell leukemia  000000  0000000 
T cell leukemia  000000  INNNINII 
Null cell leukemia  go0  000 
Myeloma  0  0 
Myeloid leukemia  O0  OO 
EBV-  B cells  00000  00000 
Skin fibmblasts  OI|INI  GG~G~ 
Rodent cells  00000  00000 
11 
FIGURE 2.  Reactivity of mAb AbK 117 and AbMC139 with cell surface antigens of cultured 
human and rodent cells. Summary of results of MHA assays using serial dilutions of antibodies 
with  127 established  human and rodent cell lines and short-term cultures  of normal cells: 
Neuroblastomas  [SK-N-SH, -BE(l), -BE(2), -MC, LA-N- 1, -2, CHP212, -234, NAP, and MC- 
NB-1 ]; astrocytomas  (SK-MG-1-9, and U251MG); melanomas (MeWo, SK-MEL-13, -28, -29, 
-113, -174, -131, -147, -178, and -186); sarcomas (RD-2, A673, SK-ES-1, 5838, 8387, A2394, 
TE-85, U20S, SAOS, and SK-CS-M); renal cancers (CAKI-1, SK-RC-1, -2, -4, -6, -7, -9, -10, - 
29, and -45); bladder cancers (253J, T24, SW780,  RT4, and TCC-SUP); colon cancers (HT- 
29, SW403,  -837, -1116,  and SK-CO-10); breast  cancers (AIAb, MCF-7, Cama, BT-20,  SK- 
BR-3, -5, -7, and MDA-MB-361); lung cancers (SK-LC-1, -6, -8, -9, and -LL); other cancers 
(A431,  SW626,  2774,  SK-OV-3, -4, -6, A10, SK-UT-1,  KNS62, and MKN45); choriocarci- 
nomas  (GCC-SV, OCC-MM, and JEG-3);  teratocarcinomas  (Tera-1,  -2, and 833KE); B cell 
leukemias (SK-LY-16, -18,  SK-DHL-2, -10,  BALL-l, DAUDI, and RAJI); T  cell leukemias 
(MOLT-4, T45,  CCRF-CEM,  -HSB2,  P12,  RPMI 8402,  PEER,  and  HPB-ALL);  null  cell 
leukemias (NALM-1, -16, and NALL-1); rnyeloma (SK-MY-1); myeloid leukemias (HL-60 and 
K562);  and  rodent  cell lines (mouse  L,  A9,  N4TG-1,  NS20TG11E, and  RAG cells; and 
Chinese  hamster  ovary cells YH21).  Results  are  indicated  as  follows: ~ , antigen-positive 
(titration  endpoints 5 x  10-5-1  ×  10-7; O ,  weak antibody reactivity (titration  endpoint 2 x 
10 -3-1 X 10-4); O, antigen-negative. 
cinomas are strong MC139 expressors  (Fig.  2).  Fibroblasts  show weak reactivity 
with AbMC139,  and a  large proportion of normal and malignant epithelial  cells 
are MC139-.  Among hematopoietic cell lines,  MC139 shows a  highly character- 
istic distribution,  being expressed  on all eight T  cell  leukemias,  but on none of 
18 cell lines derived  from B  cell,  null cell, or myeloid leukemias,  a  myeloma, or 
Epstein-Barr virus-transformed  normal B cells. 
T43, Q14, JF23, A124, G344, and NP13 Antigenic Systems.  Antigens T43  (85 
kD glycoprotein),  Q14  (130  kD  glycoprotein), JF23  (90  kD glycoprotein),  and 
A 124 have been described (4, 5,  18,  19). We have now examined the biochemical 
nature of theJF23 antigen, and Fig.  1 B shows that AbJF23 precipitates a variable 
set ofglycoproteins from extracts of different cell types, with 90 kD glycopeptides 
as a  major component  in all cell  lines tested.  The  newly derived  mAb  AbG344 
and AbNP13  were tested on the cell line panel shown in Fig. 2, and were found RETTIG  ET  AL.  1607 
FIGURE 3.  hnmunoperoxidase staining of frozen sections of fetal human thymus (A and B), 
subcutaneous tissue (C), and  adult  cerebellum  (D-F) with AbK117 (A,  C,  D, and  F) or 
unrelated antibody (B and E). Note the strong K117 reactivity in the septi and in a subpopu- 
lation of thymocytes (A), blood vessels  and connective tissue cells (C), neuronal cell bodies and 
neuropil ofcerebellar  cortex (D) and white matter (F). Hematoxylin counterstaining. Original 
magnification X 400. 
to react with all  cultured  cell types (data  not shown).  AbG344  precipitated  25 
kD glycoproteins from [SH]glucosamine and [s~S]methionine-labeled cell extracts 
(Fig.  1A).  Immunoprecipitation  experiments  with  AbNP13  did  not  yield  any 
specific components in tests with metabolically labeled cell extracts. 
Chromosomal Assignments.  mAb  AbKll7,  AbMC139,  AbT43,  AbQ14,  Ab- 
JF23,  AbA124,  AbG344,  and AbNP13  do not react with the rodent cells used 
for the generation of somatic cell hybrids, but they were reactive with character- 
istic  subsets  of the  panel  of 32  rodent-human  hybrid  clones  tested.  Table  I 
illustrates the results of MHA assays with a series of 13 mouse-human neuroblas- 
toma  hybrid clones,  and  Fig.  4  shows  the  human  chromosome content of the 
hybrids. For the eight antigenic systems studied, two patterns of reactivity were 
observed in this hybrid panel: AbJF23, AbG344, AbA124, AbT43, and AbNP13 
cotyped and reacted only with the hybrids containing a  complete human  chro- 
mosome 11.  In contrast, AbMC139,  AbK117, and AbQ14 reacted with hybrids 
containing one or more copies of either a normal human chromosome 11  or the 1608  CONTROL  OF  HUMAN  CELL  SURFACE  ANTIGENS  BY  CHROMOSOME  11 
TABLE  I 
Serological Typing of Rodent-Human Hybrid Clones with mAb Against Human 
Cell Surface Antigens 
Monoclonal antibody 
Hybrid 
JF23  G344  A124  T43  NP13  MC139  Q14  Kl17 
NBE-C2  .....  750  150  1,000 
NBE-D4  .....  150  150  1,000 
NBE-E1  1,000  150  10  1,000  250  750  150  1,000 
NBE-G1  .....  150  150  1,000 
NBE-H1  .....  150  150  1,000 
NBE-J2  .....  750  750  1,500 
NBE-K1  .....  750  150  1,500 
NBE-M1  .....  750  150  100 
NBE-N1  .....  750  150  100 
NSK-3  ........ 
NSK-4  150  1,500  10  100  750  750  750  150 
NSK-5  5,000  1,500  50  3,000  3,000  750  3,000  1,500 
NSK-6  ........ 
Serial dilutions of antibody were tested on target cells by MHA assays. Numbers indicate 
reciprocal of highest serum dilution (X  10 -s) giving rosette formation with target cells 
in  the  MHA  assay.  Negative  results  (--)  indicate  no  rosette  formation  at  starting 
dilutions of antibody (1:500 nu/nu serum or ascites). 
Human chromosomes 
Hybrid  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  ZZ  X  Y 
N~E-C2  0  e  •  (9  e  •  •  • 
NBED4  e  O~  O  •  0~  O  •  O  •  0  O~  (~  •  O 
NBEG~  Q  O  °  •  ®  ®~  •  •  0"  •  •  • 
NBEHI  •  e  e m  •  •  l  e  l"  I  • 
NBEJ2  e  e  e"  •  •  l"  l  • 
NBE-K1  0 m  •  {~m  (~  •  •  O m  • 
NBE-M1  •  •  ~  •  •  ~  •  •  (dJ  ~  Om  O  • 
NBEN1  ®  ®~  O  O ~  •  •  ®  O ~  • 
NSK3  0  •  ~  •  •  O~  Q  ~  •  • 
~sK~4  ®  •  •  •  O"  •  • ~ •  •  •  • 
NSK.~  ®  0  •  •  •  O~  •  •  •  Q  •  • 
~sK.6  Q  0  •  ~  •  ®  O  O  •  Q 
FIGURE 4.  Human  chromosome  content  of mouse-human  neuroblastoma  hybrid  clones. 
Presence of human chromosomes determined by karyotyping, isozyme analysis,  and testing of 
hybrid cells with mAb directed against 21 previously assigned cell surface markers (see Methods 
and  Materials).  0,  normal  chromosome  present;  no  entry,  chromosome  not  present; O, 
chromosome present  in <50%  of cells of a  culture; 0,  segment of chromosome present  in 
marker chromosome; O, segment present in <50% of cells.  Superscript m indicates that 2-4 
copies of the chromosome are present per hybrid cell. 
t(11 ;20) (1 1 qter- 1 1 q 13::20p 13-20qter)  marker  chromosome  previously observed 
in  the  human  parental  BE(2)-C  cells.  The  segregation  of  no  other  human 
chromosome  followed  either  of these  two  distinct  patterns  of reactivity  in  the 
hybrid  clones.  Analysis was then  extended  to the entire  hybrid  panel (32  clones) 
available  for  study.  Patterns  of  antibody  reactivity  and  distribution  of  human 
chromosomes  in the hybrid  clones were  compared  separately  for each antigenic RETTIG ET  AL.  1609 
system. For this purpose, data were collected only from hybrids derived from 
fusions  between  antigen-positive  human  cells,  and  rodent  cells  known  to  be 
permissive for the expression of the respective antigen (see below). The numbers 
of hybrid clones showing a discrepancy between antibody reactivity and presence 
of  individual  human  chromosomes  were  used  as  a  measure  of  concord- 
ant/discordant segregation, and are presented in Table II. These results show 
unequivocally that all eight antigens studied cosegregated with human chromo- 
some  11.  The  presence  of no  other  human  chromosome  was  necessary  or 
sufficient for antigen expression. For Q14 and JF23, these results confirm our 
previous findings, which had mapped gene loci MSK13  (controlling Q14) and 
MSK14 (controlling JF23) to human chromosome 11 (8). 
Regional  Assignment  of Gene  Loci  on  Human  Chromosome  11.  Presence  of 
identifiable  segments  of human  chromosome  11  (in  the  absence  of normal 
homologs of this chromosome) in at least 14 hybrid clones (shown in Figs. 4 and 
5)  has  permitted  a  subregional  assignment  on  chromosome  11  of gene  loci 
controlling antigen expression. Fig. 5 presents results of the serological typing 
with  a  discriminating panel  of seven  hybrid  clones,  each  clone containing  a 
different, unique portion of human chromosome 11. These typing results can 
be  compared  with  the  specific segments of chromosome  11  genetic material 
present in the hybrids, as determined by serological typing, karyotype analysis, 
and testing of hybrid cell DNA for the presence of human HBBC and HRAS1 
genes (Fig.  6),  which have been mapped to the distal portion of chromosome 
1 l p  (6). 
Five distinct patterns of surface antigen expression could be distinguished on 
the  hybrid  panel  for  the  eight  antigenic  systems.  Three  pairs  of antigens, 
JF23/G344,  A124/T43,  and  Q14/Kl17  segregate  independently,  and  their 
patterns of distribution are different from both the NPI 3 and MC139 patterns. 
NP13  and  MC139  show very similar patterns,  with only one discrepancy, the 
NP13-/MC 139 + hybrid clone NBE-K1. These results permit the regional assign- 
ment  of  genes  controlling JF23,  G344,  A124,  T43,  and  NP13  to  human 
chromosome  I Ipter-qI3,  and  genes  controlling  MC139,  QI4,  and  KII7  to 
human chromosome 1 lql3-qter (Fig. 7). Assuming that a minimum number of 
separate segments of chromosome 11 are present in the hybrid cells, these results 
suggest a tentative arrangement of the gene loci on chromosome 11 in the order 
1 lpter-MSK14/MSK21-MSK22/MSK23-MSK24-11  q 13-MSK25-MSK 13/ 
MSK 26 - 11 qter. 
K 117 and MC139 Are Differentially Expressed on Hybrid Cells Containing Chro- 
mosome  11.  Antigens K117,  MC139, JF23,  and Q14 are not expressed on all 
human cell types used to construct the hybrid cell panel. K117  is expressed on 
neuroblastomas, but is absent  from melanoma lines SK-MEL-29,  SK-MEL-28, 
and  MeWo,  and from normal  kidney epithelial cells.  MC139  is  expressed on 
neuroblastomas and melanomas, but not normal kidney epithelial cells. JF23 is 
expressed on all cell lines used except for SK-N-MC neuroblastoma cells, and 
Q14  is  expressed  on  all  cell  lines  used  except  for  MeWo  melanoma  cells. 
Nevertheless, we have examined all chromosome 11-positive hybrid clones for 
the expression of all eight chromosome 11-controlled antigens. We have found 
that JF23  is induced in the LMC hybrid clones, which are derived from JF23- T
A
B
L
E
 
I
1
 
D
i
s
c
o
r
d
a
n
c
y
 
A
n
a
l
y
s
i
s
 
f
o
r
 
C
h
r
o
m
o
s
o
m
a
l
 
A
s
s
i
g
n
m
e
n
t
s
 
O
'
5
 
©
 
Z
 
©
 
©
 
~
Z
 
S
u
r
f
a
c
e
 
H
y
b
r
i
d
 
H
u
m
a
n
 
c
h
r
o
m
o
s
o
m
e
s
 
a
n
t
i
g
e
n
 
c
l
o
n
e
s
*
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
1
0
 
1
1
 
1
2
 
1
3
 
1
4
 
1
5
 
1
6
 
1
7
 
1
8
 
1
9
 
2
0
 
2
1
 
2
2
 
X
 
Y
 
Z
 
J
F
2
3
 
3
2
 
G
3
4
4
 
2
3
 
A
1
2
4
 
2
5
 
T
4
3
 
3
2
 
N
P
1
3
 
2
6
 
M
C
1
3
9
 
2
2
 
Q
I
4
 
3
2
 
K
I
1
7
 
I
9
 
8
 
1
1
 
6
 
8
 
1
5
 
1
0
 
1
1
 
8
 
9
 
8
 
0
 
9
 
1
0
 
1
7
 
1
6
 
1
3
 
5
 
1
5
 
1
1
 
1
8
 
2
1
 
1
0
 
2
2
 
1
1
 
4
 
6
 
4
 
6
 
7
 
4
 
6
 
5
 
3
 
8
 
0
 
5
 
5
 
1
0
 
1
0
 
9
 
5
 
6
 
7
 
1
3
 
9
 
7
 
1
4
 
6
 
3
 
7
 
6
 
7
 
1
1
 
1
0
 
7
 
8
 
5
 
8
 
0
 
6
 
7
 
1
3
 
1
4
 
9
 
7
 
1
1
 
7
 
1
6
 
1
4
 
8
 
1
7
 
7
 
8
 
1
0
 
8
 
8
 
l
l
 
1
2
 
1
0
 
9
 
1
0
 
8
 
0
 
1
0
 
1
1
 
1
6
 
1
7
 
1
3
 
7
 
1
4
 
1
0
 
1
8
 
2
0
 
1
0
 
2
3
 
9
 
5
 
9
 
6
 
8
 
1
2
 
1
0
 
7
 
1
0
 
7
 
8
 
0
 
8
 
9
 
1
2
 
1
1
 
9
 
7
 
1
2
 
8
 
1
6
 
1
5
 
1
0
 
1
6
 
1
0
 
3
 
1
4
 
1
3
 
1
0
 
1
3
 
1
0
 
1
1
 
1
5
 
1
3
 
8
 
0
 
1
1
 
1
5
 
4
 
3
 
5
 
1
3
 
1
6
 
8
 
5
 
4
 
1
3
 
4
 
1
6
 
9
 
1
9
 
1
3
 
9
 
1
9
 
1
6
 
1
5
 
1
6
 
2
1
 
8
 
0
 
1
6
 
1
8
 
1
3
 
1
1
 
9
 
1
1
 
2
3
 
1
4
 
7
 
1
6
 
1
4
 
1
4
 
1
8
 
3
 
1
2
 
1
1
 
7
 
1
1
 
1
0
 
1
0
 
1
3
 
1
5
 
8
 
0
 
1
1
 
1
3
 
6
 
5
 
5
 
1
1
 
1
4
 
1
0
 
3
 
4
 
1
1
 
4
 
1
4
 
Z
 
N
u
m
b
e
r
s
 
o
f
 
h
y
b
r
i
d
 
c
l
o
n
e
s
 
s
h
o
w
i
n
g
 
d
i
s
c
o
r
d
a
n
c
e
 
b
e
t
w
e
e
n
 
p
r
e
s
e
n
c
e
 
o
f
 
c
h
r
o
m
o
s
o
m
e
s
 
i
n
d
i
c
a
t
e
d
 
a
b
o
v
e
 
a
n
d
 
e
x
p
r
e
s
s
i
o
n
 
o
f
 
a
n
t
i
g
e
n
 
l
i
s
t
e
d
 
o
n
 
t
h
e
 
l
e
f
t
.
 
R
e
a
r
r
a
n
g
e
d
 
-
-
 
c
h
r
o
n
m
s
o
m
e
s
 
w
e
r
e
 
n
o
t
 
a
s
s
e
s
s
e
d
.
 
H
y
b
r
i
d
 
c
l
o
n
e
s
 
i
n
c
l
u
d
e
d
 
i
l
l
 
t
h
e
 
a
n
a
l
y
s
i
s
 
w
e
r
e
 
1
9
 
i
n
d
e
p
e
n
d
e
n
t
l
y
 
d
e
r
i
v
e
d
 
N
B
E
 
a
n
d
 
N
S
K
 
c
l
o
n
e
s
 
(
f
o
r
 
a
l
l
 
a
n
t
i
g
e
n
s
)
,
 
a
n
d
 
i
n
 
a
d
d
i
t
i
o
n
,
 
c
l
o
n
e
s
 
C
E
1
2
,
 
C
E
2
5
,
 
a
n
d
 
C
C
4
 
(
f
o
r
 
M
C
1
3
9
 
a
n
d
 
G
3
4
4
)
;
 
c
l
o
n
e
s
 
R
C
4
 
a
n
d
 
R
C
6
 
(
f
o
r
 
G
3
4
4
)
;
 
c
l
o
n
e
 
L
C
1
/
3
/
4
5
 
(
f
o
r
 
G
3
4
4
,
 
A
1
2
4
,
J
F
2
3
,
 
T
4
3
,
 
a
n
d
 
Q
1
4
)
;
 
:
z
 
c
l
o
n
e
 
L
C
2
/
4
 
(
f
o
r
 
N
P
1
3
,
 
A
1
2
4
,
J
F
2
3
,
 
T
4
3
,
 
a
n
d
 
Q
1
4
)
;
 
c
l
o
n
e
 
R
A
G
4
Y
 
(
f
o
r
 
A
1
2
4
,
J
F
2
3
,
 
T
4
3
,
 
a
n
d
 
Q
1
4
)
;
 
c
l
o
n
e
s
 
R
C
2
,
 
R
C
2
/
1
3
,
 
a
n
d
 
R
C
2
/
1
7
 
(
f
o
r
 
N
P
1
3
,
 
A
1
2
4
,
 
J
F
2
3
,
 
T
4
3
,
 
a
n
d
 
Q
I
4
)
;
 
c
l
o
n
e
s
 
L
N
K
I
,
 
R
C
1
/
7
,
 
a
n
d
 
R
C
1
/
9
 
(
f
o
r
 
N
P
I
3
,
J
F
2
3
,
 
T
4
3
,
 
a
n
d
 
Q
I
4
)
;
 
a
n
d
 
c
l
o
n
e
s
 
L
N
K
1
/
6
,
 
L
N
K
I
/
8
,
 
L
N
K
1
/
1
5
,
 
a
n
d
 
R
C
1
/
2
 
(
f
o
r
J
F
2
3
,
 
T
4
3
,
 
a
n
d
 
Q
I
4
)
.
 
*
 
T
o
t
a
l
 
n
u
m
b
e
r
s
 
o
f
 
h
y
b
r
i
d
 
c
l
o
n
e
s
 
e
v
a
l
u
a
t
e
d
 
f
o
r
 
i
n
d
i
v
i
d
u
a
l
 
a
n
t
i
g
e
n
i
c
 
s
y
s
t
e
m
s
.
 
:
Z
 
©
 
O
 
©
 RETTIG  ET  AL, 
HYBRID CLONE 
1611 
SURFACE  ANTIGEN 
~1F23 
G  344, 
~,124 
T43 
NP13 
MC1~9 
Q14 
K117 
NSK-1  NSK-2 NSK-Is  N?~-7  NSK-IO NSK-~ NBE-K1 
I 
nu  I  II,. 
HI  NI 
HUMAN  DNA  SEQUENCE 
H -ras  +  +  +  .... 
/9-globin  +  +  +  .... 
CHROMOSOME  l 1  FRAGMENT 
ml  tn,3  m7  n d  n d  m5  m6 
¢n2  m4 
FXGUnE 5.  Differential expression of chromosome l 1-controlled human cell surface antigens 
on a discriminating rodent-human  hybrid pane[. Surface antigen expression on hybrid cells is 
indicated  by  filled  rectangles,  no  entry  indicates  lack  of antigen  expression.  Presence  of 
karyotypically  defined  segments  of  chromosome  11  is  indicated  as  ml-6.  Segment  ml, 
del(11)(pter-ql 3), comprises chromosome 1 lp and the proximal portion of 1 lq; m2 is probably 
a rearranged  m4 marker chromosome, including bands  1 lql 3-1 lq22; m3 is a small marker 
chromosome possibly derived from chromosome 11; m4 is the marker chromosome, t(11;20), 
present in the parental  SK-N-BE(2) cells; m5 and m6 comprise the segment  l lq13-1 lqter. 
Hybrid clones NSK-7 and NSK-10 contain no markers karyotypically identified as comprising 
11  material, although both contain several rearranged chromosomes with small unidentified 
chromosomal segments. The human LDH-A isoenzyme is not consistently detectable in human 
×  mouse neuroblastoma hybrids containing a normal human chromosome 11  (N. Dracopoli, 
unpublished observations), and therefore results are not included here. 
SK-N-MC cells (Fig. 8). No induction was observed for K117, MC139, and QI4 
in  the  hybrids.  However,  differences  were  found  in  the  levels  of Kl17  and 
MC139  expression  in  chromosome  l 1-containing  hybrids  derived  from 
K117+/MC139 + human  neuroblastomas  (NBE,  NSK,  and  LMC hybrid  series) 
and MC139 + human melanomas (LM and AM series), depending on the cell type 
of the rodent  fusion  partner.  NBE and  NSK hybrids,  constructed with  mouse 
neuroblastoma cells, were strong K 117 and MC 139 expressors. In contrast, LMC 
hybrids,  constructed  with  mouse  L  cells,  showed  little  or  no  reactivity  with 
AbK117 and AbMC139, and AM and LM hybrids, also constructed with L cells 
or A9 cells, showed no reactivity with AbMC139 (Fig. 8). The finding that seven 
independently derived LMC hybrid clones showed weak AbK117 reactivity, and 
five  LMC  clones  showed  weak  AbMC139  reactivity  (rather  than  a  complete 
absence of the  antigens)  is significant  in  the  interpretation  of these results.  It 
demonstrates  that  the  Kl17  and  MC139  coding  sequences are  present  in  the 
hybrid cells, and that regulatory mechanisms characteristic for the rodent fusion 
partner control antigen expression in the hybrids. 
Discussion 
The Thy-1 antigen of mouse thymocytes (21) was one of the first examples of 
a group of serologically defined cell surface components designated as differen- 
tiation antigens (22). Studies by several investigators (23, 24) have subsequently F
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11 
FIGURE  7.  Regional  assignment  of  gene  loci  on  human  chromosome  1 1  controlling  ce[I 
surface antigens. Bars indicate shortest regions of overlap. The location of the HRASI  gene, 
the  WAGR  locus  of Wilms' tumor and the breakpoint on chromosome  i I  in  the t(l I;22) 
marker chromosome of Ewing sarcomas (arrowhead) are indicated, 
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ANTIBODY DILUTION (x 103) 
FIGURE 8.  Differential expression of K 117, MC 139, and JF23 cell surface glycoproteins on 
rodent-human  hybrid cells  containing human  chromosome  11.  Diagrams show  results of 
representative titration experiments with AbK117, AbMC139, and AbJF23 on human and 
rodent parental cell lines, and on hybrid cell lines using the MHA assay. Cell lines are indicated 
as follows:  I, 0,  SK-N-BE(2) and SK-N-MC  human  neuroblastoma lines; O,  N4TG-I  and 
NS20TGI 1E mouse neuroblastomas; Fl, mouse L cells. Hybrid clones were: ~, NBE-J2; ~, 
NSK-Is; r~, LMC5; K-I, LMC4, [], LMCI8.7; and IP1, LMC17. 
identified putative rat, human,  and canine Thy-1 molecules, mAb Ab390, which 
detects a  24  kD glycoprotein in human  brain extracts, has been reported  (25) as 
recognizing human  Thy-1.  The  reactivity of Ab390  with  a  panel  of 29  human 
cell  lines  and  a  range  of normal  tissues  has  been  described  (25),  and  closely 
resembles the pattern defined for K117  in the more extensive analysis presented 1614  CONTROL  OF  HUMAN  (;ELL  SURFACE  ANTIGENS  BY  CHROMOSOME  11 
here. The molecular masses of the K117 and 390 molecules are also comparable. 
Using the immunoperoxidase  method, we found that  AbK117 shows the same 
staining pattern in fetal thymus and several other tissues that has been described 
for F15-42-1, another  mAb reported  to detect human  Thy-1  (26).  Therefore, 
AbK117 most likely also recognizes human Thy-1. Our finding that the MSK26 
gene  locus (controlling  K117 expression)  maps to human  chromosome  1 lql3- 
qter is consistent with this conclusion, since it places human Thy-1 into the same 
linkage  group  (including  Ioci APOA1, UPS, and ESA4 in  man  and Apl-1, Ups, 
and Es-17 in the mouse) that resides on the Thy-l-carrying chromosome 9 in the 
mouse (27, 28). 
The  chromosomal  assignment  of antigens  K117,  MC139,  Q14,  and JF23, 
which show a restricted or intermediate distribution on the cultured human cell 
pane] and which follow differentiation  patterns,  permits the analysis of antigen 
expression in human chromosome 11-containing hybrids constructed with anti- 
gen-positive or antigen-negative  human  cells and rodent cells of distinct differ- 
entiation  lineages.  The results demonstrate different regulatory principles gov- 
erning surface expression of these antigens in hybrid cells. For K117 and MC139, 
antigens  strongly  expressed  on  human  neuroblastomas,  we  have  found  that 
human-mouse  neuroblastoma  hybrids (NBE and  NSK clones) are strong K117 
and  MC139  expressors (see Fig.  8).  In  contrast,  hybrids derived from human 
neuroblastoma  cells and  mouse L  cells showed little  or no  K117  and  MC139 
expression, and  hybrids derived from human  melanoma  cells (MC139+/Kll 7- 
phenotype) and mouse A9 or L cells were consistently MC139-, suggesting tissue- 
specific regulation  of K117 and  MC139 in hybrid cells, determined  by the cell 
type of the rodent fusion partner.  Mouse neuroblastoma cells are permissive for 
K117 and  MC139, but mouse A9 and  L cell fibroblasts are not.  Similar results 
have been reported for the expression of mouse Thy-t in rodent cells transfected 
with a  cloned mouse Thy-1 gene,  with  mouse lymphoma and  rat neural  tumor 
cells being permissive, and L cells being nonpermissive for Thy-1 (29). For JF23, 
we have found that fusion of cells of the JF23- human  neuroblastoma line SK- 
N-MC with mouse L cells results in cells expressingJF23 (Fig. 8). This inducing 
phenotype of L cells for JF23 expression  resembles the F8  induction described 
(8) for L cell hybrids containing human chromosome  19, and contrasts with the 
permissive/noninducing  phenotype  of L  cells  for  Q14  (8),  confirmed  in  this 
study. Among the neuroblastoma  hybrids, induction  of F8 and JF23  is seen in 
clones characterized  by fibroblastic morphology and  increased  substrate  adhe- 
siveness compared  to the human  parental  cells (LMC and certain  NSK hybrid 
clones) (8).  Typically, cultured human  neuroblastoma  cells show a  neuroblastic 
morphology,  with  round cell bodies and  neuritic  processes, and adhere  poorly 
to  the  culture  flask  substratum.  However,  variant  cells  with  an  epithelial  or 
fibroblast-like morphology have been derived from several of the neuroblastoma 
cell  lines  (30).  These  variants  are  strongly  substrate-adherent  and  exhibit  an 
F8+/JF23 + surface phenotype. As F8 andJF23 expression seem to be related to 
the  same  cellular  growth  characteristics  in  both  neuroblastoma  variants  and 
hybrid cells, these antigens may have a direct role in cell adhesion. Thus, different 
regulatory principles determining surface antigen expression in hybrid cells have 
been identified in our analysis.  Some human  differentiation antigens are tightly RETTIG ET  AL.  1615 
TABLE  Ill 
Human Cell Surface Antigenic Systems Controlled by Genes on Human Chromosome 11 
Surface antigenic system  Chromosome 
Name  Description  assignment  Gene designation*  Reference 
JF23  90 kD glycoprotein  1 lpter-ql 3  MSKI4  8 
G344  25 kD glycoprotein  11 pter-q 13  MSK21 
A 124  1 I pter-q 13  MSK22  5 
T43  85 kD glycoprotein  11 pter-q 13  MSK23  4 
N P 13  11 pter-q 13  MSK24 
MC139  35 kD glycoprotein  1 lql3-qter  MSK25 
Q 14  130 kD glycoprotein  11 q 13-qter  MSKI3  8,  19 
K I 17  25 kD glycoprotein  11 q 13-qter  MSK26 
W6/34  glycolipid  1 lpter-pl 3  MIC1  7 
F10.44.2  80 kD polypeptide  1 lpter-pI3  MIC4  38, 39 
A3D8  80 kD glycoprotein  I lpter-pl 1  MDU2  11 
4F2  80/40 kD glycoprotein  11 q 13-q22  MDUI  11, 39, 40 
4D12  100 kD polypeptide  1 lq22-qter  MIC9  10, 39 
LEU7  200/140 kD glycoprotein  11  LEU7  31,41 
* Chosen according to conventional nomenclature rules (6). 
controlled by the phenotype of the rodent fusion partner (inducing and permis- 
sive/nonpermissive modes of expression; see K117 and MC139,  or A0122 and 
F23  [8]).  Other  antigens  are  controlled by  the  growth  characteristics of the 
hybrid cells (inducing and conditionally permissive modes of expression; seeJF23 
or F8 [8]). Some antigens show no such regulatory influence (generally permissive 
and noninducing modes of expression; see Q14). Fundamentally different genetic 
mechanisms may be involved in the control of these groups of antigens, not only 
in hybrid cells, but also in human parental cells. 
The distinctive nature of each of the eight antigens described in this study has 
been  demonstrated  by  a  combination  of serological,  biochmical,  and  genetic 
methods. Using this approach, the antigens can be compared with cell surface 
antigens previously assigned to human chromosome 11. Antigens K 117, MC 139, 
T43, Q14, G344, and NP 13 are readily distinguished from previously assigned 
antigens based on their characteristic distribution, their biochemical character- 
istics,  and their regional assignments on chromosome 11  (see Table  III).  The 
relationship between  JF23, A3D8/A 1G3, and F 10.44.2 remains to be established, 
particularly since AbJF23 recognizes a variable set of glycopeptides in different 
cell  types (Fig.  1).  A124  has  biochemical characteristics of a  glycolipid,  and 
resembles in this regard and in its wide distribution the W6/34 and E7 antigens 
(A. Houghton, Memorial Sloan-Kettering Cancer Center, personal communica- 
tion). However, human erythrocytes  are A 124-, E7 +, and W6/34 +, and therefore 
AbA124 seems to define a new antigenic system. Our results and those described 
by others (10, 31) show that human chromosome 11  controls the expression of 
at least 12 cell surface antigens (Table III). This contrasts with the small number 
of surface antigens known to be controlled by other human chromosomes (6). 
At least two general mechanisms can account for this clustering of assignments 
for surface antigens defined by mouse mAb: Human chromosome 11  may have 
an important role in constructing the human cell surface, and may code for a 1616  CONTROL  OF  HUMAN  CELL  SURFACE  ANTIGENS  BY  CHROMOSOME  11 
large number of surface antigens. Alternatively, chromosome 11-controlled cell 
surface components may be particularly immunogenic in mice and therefore be 
more  readily  detected  by  mouse  mAb  technology  than  surface  components 
encoded by other human chromosomes. 
Considerable attention  has been directed recently towards the occurrence of 
nonrandom  chromosome rearrangements  in a number of human  malignancies, 
and  the  possible  involvement  of  gene  loci  spatially  related  to  chromosome 
deletions or break points in generating  the malignant  phenotype (32).  Cellular 
oncogenes and  genes involved in  the  control  of cell  proliferation  and  cellular 
differentiation  have been of particular  interest  in  this  regard.  Various mecha- 
nisms have been proposed (32,  33) that  could result in increased expression of 
these  genes,  or in  the  expression  of altered  gene  products,  both  leading  to a 
disturbance of cellular differentiation or growth control. Nonrandom rearrange- 
ments of chromosome 11 have been associated with hematopoietic malignancies, 
Wihns'  tumors,  and other cancers.  So far, no close association has been found 
between the regions on chromosome 11 involved in specific rearrangements and 
any known gene locus, including the HRAS1 protooncogene (34). Therefore, it 
seems important to define new gene loci on chromosome 11, especially gene loci 
that  are  actively  transcribed  in  specific  tumor  cells,  and  genes  that  specify 
proliferation or transformation-related  cellular traits.  In addition, gene loci that 
are  closely  related  to  breakpoints  may  provide  markers  for  further  genetic 
studies, even if they are not involved in disturbances of cellular proliferation or 
differentiation. Certain antigenic systems described here deserve special attention 
with  regard  to  the  transformed  phenotype.  A  specific  translocation,  t(11;22) 
(q24;q12),  has been described for Ewing sarcomas (35,  36);  moreover,  Geurts 
van  Kessel et al.  (37) have shown  that  the c-sis oncogene is translocated  from 
chromosome 22 to the rearranged chromosome 11 in a Ewing sarcoma cell line. 
Conceivably,  such  a  translocation  could  bring  c-sis  into  the  proximity,  and 
possibly under the influence of genes located on chromosome 1 lq. Both MSK25 
(controlling MC 139) and MSK26 (controlling K117) map to this region (1 lql 3- 
qter), and MC 139 and K 117 are expressed at high levels in Ewing sarcoma cells. 
Therefore, it is important  to determine more precisely the localization of these 
genes relative to the breakpoint region, and to investigate their possible effects 
on c-sis expression. The translocation of c-myc to the Ig gene cluster provides a 
precedent for such an interaction (33), and it may be important that Ig and Thy- 
1 belong to a common family of related cell surface and secreted glycoproteins 
(38). In the case of the T43 antigenic system, it may be significant that we have 
now mapped MSK23 (controlling T43) to chromosome 11 pter-q 13. Fradet et al. 
(4)  have  shown,  in  an  immunohistochemical  study  of normal  and  malignant 
human  tissues,  that  T43  is a  marker  of malignant  tumors derived from T43- 
epithelia.  15 malignant tumors of bladder, colon, lung, and breast all had a T43 + 
phenotype, while the corresponding normal epithelia,  and nine cases of benign 
tumors derived from these tissues were T43- (4).  It is tempting to speculate that 
T43  is  not  only  a  marker  of malignant  tumors,  but  is  directly  involved  in 
generating  the  malignant  phenotype, and  the  rearrangements  of chromosome 
11  may contribute  to  the  malignant  behavior  of tumor  cells by changing  the 
pattern of T43 expression, or through  expression of an altered T43 molecule. RETTIG  ET  AL.  1617 
Fine  mapping  of MSK23  on  chromosome  11,  through  serological  analysis of 
somatic cell hybrids, including hybrids constructed with cells from Wilms' tumor 
patients (34), will be an important next step in this analysis. 
Summary 
The  expression  of eight serologically and  biochemically distinct human cell 
surface antigens defined by monoclonal antibodies was examined on a  panel of 
rodent-human  somatic  cell  hybrids.  Cosegregation  was  observed  for  human 
chromosome 11, and surface expression of all eight antigens was studied. Sero- 
logical analysis of hybrids containing defined segments of human chromosome 
11 permitted the regional assignment of genes controlling antigens JF23 (90 kD 
glycoprotein), G344  (25  kD),  T43  (85  kD),  A124,  and  NP13  to chromosome 
1 lpter-q13, and of genes controlling Q14 (130 kD), MC139 (35 kD), and K117 
(25  kD) to chromosome  1 lql3-qter.  K117, the putative human Thy-1 antigen, 
was expressed at high levels in chromosome 11-containing hybrids constructed 
with mouse neuroblastoma ceils, but showed little or no expression in hybrids 
constructed with mouse L  cells. A  similar pattern of expression in hybrids was 
found for MC 139, an antigen shared by neuroectoderm-derived cells and normal 
and malignant T  lymphocytes. T43  is a  marker of malignant tumors (but  not 
benign  tumors)  derived  from  a  number  of T43-  epithelia,  and  the  regional 
assignment of the T43 locus on chromosome 11 raises questions about its possible 
involvement in the specific rearrangements of this chromosome seen in human 
malignancies. 
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